Fluorogenic
organic materials have gained tremendous attention
due to their unique properties. However, only a few of them are suitable
for bioimaging. Their different behaviors in organic and cellular
environments hinder their application in bioimaging. Thus understanding
the photoluminescent behaviors of organic materials in a cellular
context is particularly important for their rational design. Herein,
we describe two coumarin-quinazolinone conjugates: CQ and MeCQ. The high structure similarity makes them
possess similar physical and photophysical properties, including bright
fluorescence ascribed to the monomer forms in organic solvents and
aggregation-caused quenching (ACQ) effect due to self-assembly aggregation
in aqueous solution. However, they behave quite differently in cellular
context: that is, CQ exhibits bright fluorescence in
living cells, while the fluorescence of MeCQ is almost
undetectable. The different performance between CQ and MeCQ in living cells is attributed to their different scenario
in G-quadruplex (G4) DNA interaction. CQ selectively
binds with G4 DNA to recover its fluorescence via aggregation–disaggregation switching in living cells, while MeCQ remained in the aggregate form due to its poor interplay
with G4 DNA. Furthermore, CQ is applied as a two-photon
fluorescent dye, and its photoswitchable fluorescence capability is
exploited for super-resolution imaging of the specific mitochondrial
structure in living cells via the STORM technique.
Probes based on the intramolecular tetrazole-ene photo-click reaction were developed for the in situ fluorescence imaging of mitochondria and lysosomes in living cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.